Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Quickcomparison

Dose Range Nafarelin As prescribed–As prescribed mg Buserelin 200 mcg–1,500 mcg mcg Frequency Once daily Administration As directed by healthcare provider Subcutaneous injection Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level St

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Dose Range
  • Nafarelin
  • As prescribed–As prescribed mg
  • Buserelin
  • 200 mcg–1,500 mcg mcg
  • Frequency
  • Once daily
  • Administration
  • As directed by healthcare provider
  • Subcutaneous injection
  • Cycle Length
  • Ongoing/indefinite
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Strong human trials (Phase 3 or FDA approved)
  • Efficacy